Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12Other 3Gastrointestinal 3Thoracic 2Head & Neck 2Gynecologic 2Sarcoma 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 1568Glioblastoma 512Gliosarcoma 485Osteosarcoma 458Brain Neoplasms 344Gastrointestinal Stromal Tumors 324Central Nervous System Neoplasms 296Neoplasms 291Dendritic Cell Sarcoma, Interdigitating 286Astrocytoma 275Lymphoma 259Bone Neoplasms 243Breast Neoplasms 237Sarcoma, Ewing 236Glioma 236Neuroblastoma 230Rhabdomyosarcoma 226Melanoma 224Precursor Cell Lymphoblastic Leukemia-Lymphoma 218Recurrence 216Lymphoma, Non-Hodgkin 216Burkitt Lymphoma 213Oligodendroglioma 203Ovarian Neoplasms 200Lymphoma, Large B-Cell, Diffuse 187Neoplasm Metastasis 186Lymphoma, Follicular 172Leukemia 164Leukemia, Lymphocytic, Chronic, B-Cell 158Hodgkin Disease 158

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Risk Reduction Behavior × Sarcoma × Clear all
NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

Region Stockholm

Phase NA Enrolling by invitation
300 enrolled
Sarcoma

Sarcoma, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡